- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT03057639
Clinical Model in Evaluating Clinical, Psychosocial, and Health Economic Factors in Adolescent and Young Adult Patients With Cancer
Adolescent and Young Adult (AYA) Cancers Clinical Model: An Evaluation of the AYA Clinical Care Model by Assessment of Clinical, Psychosocial, and Health Economic Factors Related to AYA Patient Outcomes
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
PRIMARY OBJECTIVES:
I. To provide economic understanding of the AYA at University of Southern California (USC) model of care. (Norris)
II. To evaluate the existing AYA at USC program to determine the direct and indirect impact on cost of care. (Norris)
III. To utilize the results of objective (i) to identify cost effectiveness and efficiencies to patient and institution. (Norris)
IV. To identify specific processes within our model of care that can be improved. (Norris)
V. To improve healthcare access to AYA-specific cancer care for patients ages 15-39 served by the Los Angeles County (LAC)+USC oncology pilot clinics. (LAC+USC)
VI. To improve the psychosocial outcome of AYA-specific cancer care patients. (LAC+USC)
VII. To provide AYA specific elements of care routinely and proactively to AYA cancer patients. (LAC+USC)
VIII. To improve care quality through patient satisfaction. (LAC+USC)
IX. To improve resource utilization and care coordination through improved patient navigation through efficiency and patient navigation. (LAC+USC)
OUTLINE:
Patients complete questionnaires at referral, week 4-8, week 10-12, and at the completion of systemic therapy.
Studietype
Inschrijving (Werkelijk)
Contacten en locaties
Studie Locaties
-
-
California
-
Los Angeles, California, Verenigde Staten, 90033
- USC / Norris Comprehensive Cancer Center
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
- Patients diagnosed with cancer
- ADDITIONAL GRANT SPECIFIC INCLUSION CRITERIA - UNIHEALTH (NORRIS):
- Patients who were diagnosed at USC Norris Comprehensive Cancer Center and Hospital
- Patients who are currently receiving treatment for a primary or secondary tumor at USC Norris Comprehensive Cancer Center and Hospital
- ADDITIONAL GRANT SPECIFIC INCLUSION CRITERIA - QUEENSCARE (LAC + USC):
- Patients who are being seen in sarcoma, gynecologic oncology, or genitourinary clinic at LAC + USC (clinics A2C or 4P1)
- Patients who are currently receiving treatment for a primary or secondary tumor at LAC + USC and who receive oncology care from one of the clinics above
- Patients who are at or below the poverty level
Exclusion Criteria:
- Inability to sign informed assent and/or consent
- Patients who are not receiving chemotherapy and/or radiation therapy for a primary or secondary tumor
- Primary oncology treatment team believes that participation in AYA at USC would not benefit their patient
- ADDITIONAL GRANT SPECIFIC EXCLUSION CRITERIA - UNIHEALTH (NORRIS):
- Patients who are not receiving treatment for a primary or secondary tumor at USC Norris Comprehensive Cancer Center and Hospital
- ADDITIONAL GRANT SPECIFIC EXCLUSION CRITERIA - QUEENSCARE (LAC+USC):
- Patients who are not receiving oncology care for a primary or secondary tumor in sarcoma, gynecologic oncology, or genitourinary clinic at LAC + USC (clinics A2C or 4P1)
- Patients who are above the poverty level
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Observatiemodellen: Case-Alleen
- Tijdsperspectieven: Prospectief
Cohorten en interventies
Groep / Cohort |
Interventie / Behandeling |
---|---|
Observational (questionnaires)
Patients complete questionnaires at referral, week 4-8, week 10-12, and at the completion of systemic therapy.
|
Nevenstudies
Andere namen:
Nevenstudies
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Clinical care model impact on patient access to AYA specific supportive care as assessed by questionnaires (Norris)
Tijdsspanne: Up to 2 years
|
Questionnaire scores will be expressed as median values with 95% confidence intervals.
|
Up to 2 years
|
Clinical care model impact on patient's/health care professional's satisfaction with the AYA at USC program as assessed by questionnaires (LAC+USC)
Tijdsspanne: Up to 2 years
|
Questionnaire scores will be expressed as median values with 95% confidence intervals.
|
Up to 2 years
|
Cost of care (Norris)
Tijdsspanne: Up to 2 years
|
Direct health care costs analyses will be performed from the Total Costs of Care payer perspective.
Direct cost will be estimated from paid claims in the extracted electronic medical records, which will include costs for all health care utilization such as outpatient, procedures, laboratory, emergency room visits, hospitalization, and pharmacy.
As the healthcare utilization and costs will likely be extremely skewed, healthcare utilization and cost measures will be estimated by using an econometric model (e.g., a negative binomial regression model for utilization count data [number of services
|
Up to 2 years
|
Incremental cost (Norris)
Tijdsspanne: Up to 2 years
|
The incremental cost between AYA enrolled and non-enrolled will be calculated.
In addition to estimation the magnitude of the variability attributed to the different sources of variation, we will also generate an influence diagram (also known as tornado diagram) to display which variables exert the most influence on cost driver.
|
Up to 2 years
|
Processes that can be improved (Norris)
Tijdsspanne: Up to 2 years
|
Will utilize the prospective data to estimate key aspects of the AYA at USC service.
Any variances in the services over time will be utilized to improve quality and reliability care delivery.
|
Up to 2 years
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Care coordination as assessed by the mean number of supportive care referrals, telephone or email encounters for additional information, educational materials, and or additional interventions provided by the nurse navigator and/or social worker (LAC+USC)
Tijdsspanne: Up to 2 years
|
Will be measured using an implementation guide.
|
Up to 2 years
|
Patient continuity of care as assessed by the mean number of visits per patient with the assigned clinic lead physician (LAC+USC)
Tijdsspanne: Up to 2 years
|
Will be measured using an implementation guide.
|
Up to 2 years
|
Resource allocation as assessed by the mean number of supportive care referrals and per patient follow-up conducted by the nurse navigator and/or social worker (LAC+USC)
Tijdsspanne: Up to 2 years
|
Will be measured using an implementation guide.
|
Up to 2 years
|
Satisfaction of health care staff as assessed by questionnaires (LAC+USC)
Tijdsspanne: Up to 2 years
|
Questionnaire scores will be expressed as median values with 95% confidence intervals.
|
Up to 2 years
|
Satisfaction of services as assessed by questionnaires (LAC+USC)
Tijdsspanne: Up to 2 years
|
Questionnaire scores will be expressed as median values with 95% confidence intervals.
|
Up to 2 years
|
Medewerkers en onderzoekers
Medewerkers
Onderzoekers
- Hoofdonderzoeker: James Hu, MD, University of Southern California
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 0S-16-6 (Andere identificatie: USC / Norris Comprehensive Cancer Center)
- P30CA014089 (Subsidie/contract van de Amerikaanse NIH)
- NCI-2017-00210 (Register-ID: CTRP (Clinical Trial Reporting Program))
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
product vervaardigd in en geëxporteerd uit de V.S.
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Kwaadaardig neoplasma
-
Istituto Clinico HumanitasWervingDISTALE MALIGNANT BILIAIRE OBSTRUCTIEItalië
Klinische onderzoeken op Beoordeling van de kwaliteit van leven
-
NLT SpineOnbekendDegeneratieve schijfziekteIsraël
-
Vanderbilt University Medical CenterNational Institute of Mental Health (NIMH)WervingAutisme Spectrum StoornisVerenigde Staten
-
Mazor RoboticsVoltooidOnder rug pijnDuitsland, Israël
-
Vanderbilt University Medical CenterNational Institute of Mental Health (NIMH)WervingAutisme Spectrum StoornisVerenigde Staten
-
The Hospital for Sick ChildrenCanadian Institutes of Health Research (CIHR)Voltooid
-
Al-Azhar UniversityWervingCariës | Uitbarsting | Body Mass IndexEgypte
-
Umraniye Education and Research HospitalVoltooidSlaap stoornis | Chirurgie | Obesitas, ernstigKalkoen
-
Ibn Sina HospitalBanon IVF Center Assiut, EgyptVoltooid